Vertex Pharmaceuticals Inc
VRTX· Nasdaq
Released Oct 29, 2020, after the close
10-Q filed Oct 30, 2020, 30 days after period end · 0000875320-20-000043
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $1.54B | $949.83M | $784.54M | $578.17M |
| Net Income | $667.43M | $57.52M | $128.75M | -$102.95M |
| EPS Diluted |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $2.53 |
| $0.22 |
| $0.50 |
| -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.